CBIO- Crescent Biopharma, Inc.
Crescent Biopharma, Inc. (CBIO) has 13 insiders with recent SEC Form 4 filings, including 11 buys and 9 sells. CBIO is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.75M | $48.61M | - | |
| CEO | 323.5K | $5.72M | - | |
| COO | 153.7K | $2.72M | - | |
| Other | 70.0K | $1.24M | - | |
| Other | 54.2K | $958.7K | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2020 | King Rachel K. | President, CEO | Sale+OE | 84,176 | $3.91 | $329,128.16 | -19.1% | |
| Nov 4, 2020 | Bvf Partners L P/il59 | 10% Owner | Buy | 1,266,737 | $2.60 | $3,293,516.20 | +15.7% | |
| Oct 30, 2020 | Bvf Partners L P/il59 | 10% Owner | Buy | 932,612 | $2.75 | $2,564,683.00 | +13.1% | |
| Mar 9, 2020 | Junius Daniel M | Director | Buy | 20,000 | $3.40 | $68,000.00 | +111.1% | |
| Sep 5, 2019 | Bvf Partners L P/il59 | 10% Owner | Buy | 1,668,746 | $3.18 | $5,309,949.77 | +30.6% | |
| Aug 13, 2019 | Junius Daniel M | Director | Buy | 10,000 | $3.18 | $31,800.00 | +125.0% | |
| Oct 18, 2018 | Magnani John L. | SVP Of Research, CSO | Sell | 25,000 | $14.01 | $350,212.54 | -9.4% | |
| Jun 11, 2018 | Hahn Brian M.47 | CFO | Sale+OE | 19,345 | $18.04 | $348,983.80 | -100% | |
| May 10, 2018 | Sandell Scott D55 | 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - | |
| May 10, 2018 | New Enterprise Associates 10 L P | 10% Owner | Sell | 9,539 | $17.81 | $169,889.59 | - |